Leading market share in NASH treatments by end of 2024?

Viking Therapeutics' stock price up 20% by end of Q3 2024?

Phase 3 trial announcement for VK2809 by end of Q1 2024?

Next major therapeutic area for Viking Therapeutics by mid-2024?

FDA approval for VK2809 by end of 2024?

Will Novo Nordisk announce a new Phase 3 trial for CagriSema by end of 2025?

Will Novo Nordisk's CagriSema receive FDA approval by end of 2025?

Will Viking Therapeutics' stock price double by mid-2025?

Will Viking Therapeutics' stock price reach $100 by end of 2024?

Will Eli Lilly surpass Novo Nordisk in obesity drug market share by end of 2025?

Will Novo Nordisk's market cap recover to pre-drop levels by June 30, 2025?

Market leader in obesity drugs by market cap by end of 2025

Which company will lead the weight loss drug market by end of 2025?

Will Novo Nordisk's stock recover to pre-announcement levels by December 31, 2025?

Which company will see the highest stock price increase in 2025 among major weight loss drug developers?

Outcome of Novo Nordisk's next major obesity drug trial by December 31, 2025?

Which company will lead the weight loss drug market by December 31, 2025?

Will Eli Lilly surpass Novo Nordisk in market capitalization by December 31, 2025?

Will Novo Nordisk announce a new CagriSema trial with improved results by June 30, 2025?

Will Novo Nordisk stock recover to $125 by June 30, 2025?

Will Viking Therapeutics start Phase 2 study of VK2735 by Dec 31, 2024?

Will VK2735 receive FDA Fast Track designation by 2025?

Viking Therapeutics initiates Phase 2 study of oral VK2735 by end of 2024?

FDA approval status of VK2735 for obesity by end of 2025?

Viking Therapeutics stock price rises another 20% by end of 2024?

CagriSema weight loss percentage milestone in 2025

Next major Novo Nordisk obesity treatment announcement by end of 2025

What will Novo Nordisk do next with CagriSema by end of 2025?

Will Eli Lilly's ZepBound have a higher market share than Novo Nordisk's CagriSema by end of 2025?

Will Novo Nordisk's stock price recover to pre-announcement levels by June 30, 2025?

How will Novo Nordisk's share price performance compare to Eli Lilly by end of 2025?

What will be identified as the primary reason for CagriSema's failure in future analyses by end of 2025?

Will Eli Lilly's obesity drug surpass CagriSema in market share by end of 2025?

Which company will release the next major obesity drug post-CagriSema trial by end of 2025?

What will Novo Nordisk's stock price be at the end of Q2 2025?

Will CagriSema achieve target weight loss in future Phase 3 trial by end of 2025?

What weight loss will VK2735 Phase 2 study achieve?

Which company will Viking partner with for VK2735 by 2025?

Will Viking discuss VK2735 clinical path with FDA by Dec 31, 2024?

Will VK2735 Phase 2 study report moderate/severe nausea?

Viking discusses VK2735 injectable with FDA by end of Q4 2024?

Outcome of Phase 2 study of oral VK2735 by mid-2025?

VK2735 market share vs competitors by end of 2025?

VK2735 market share in obesity drugs by end of 2025?

Outcome of next major VK2735 trial by mid-2025?

Will Viking start Phase 2 trials for VK2735 by end of 2024?

Will VK2735 receive FDA approval by end of 2025?

Who will lead the obesity treatment market by end of 2025?

What will be the next major milestone announcement for VK2735 by November 2025?

What will be VK2735's market share in obesity drugs by end of 2025?

Will Viking Therapeutics partner with a major pharmaceutical company for VK2735 by November 2025?

Will Viking Therapeutics initiate Phase 2 trial for VK2735 by mid-2025?

How will Viking Therapeutics stock performance compare to Novo Nordisk and Eli Lilly by end of 2024?

NASH resolution percentage in Phase 3 trial for VK2809 by end of 2025?